Assessing the relationship of respiratory muscle strength and cytokine status in patients with community-acquired pneumonia

Aim. Assessment of the role of cytokine-mediated changes in the development of respiratory muscle (RM) dysfunction in patients with community-acquired pneumonia (СAP). Methods. 84 men aged 18 – 26 years with a median of age 19.5 [18.4; 22.8]. Mild to moderate CAP (MCAP) was diagnosed in 62 (73.8%) patients and severe (SCAP) in 22 (26.2%). The expiratory (MEP, MRPD_out) and inspiratory (MIP, MRPD_in. SNIP) strength indices of RM were recorded on a MicrоRPM apparatus (CareFusion, UK). The severity of endogenous intoxication was verified using the following indices: hematologic (HII), leukocyte (LII), and nuclear. Serum concentrations of interleukins-2, -8, -10, basic fibroblast growth factor, transforming growth factor-beta, tumor necrosis factor-alpha (TNF-α), and a soluble receptor for TNF-α. Data processing was performed by cluster and correlation analysis methods. Results. Three clusters of patients with CAP were identified by the characteristic combinations of indicators of RM strength, endogenous intoxication, and cytokine status. The first cluster had MCAP, the second – both MCAP and SCAP, the third – SCAP. In the first cluster, dysfunction of expiratory RM prevailed, and in the second and third – dysfunction of inspiratory RM. In the midst of CAP, significant negative correlations of RM strength indicators with LII, HII, TNF-α, IL-10, IL-8, and IL-2 levels were recorded. The endogenous intoxication indices reached control values in all patients during recovery. The first cluster showed a decrease in the level of analyzed cytokines against isolated dysfunction of expiratory RM. The second cluster showed a tendency toward restoration of TNF-α and IL-8 levels, and only their SNIP index was normal. The third cluster showed minimal medians of RM strength against the continuing imbalance in the profile of pro- and anti-inflammatory cytokines during recovery. Conclusion. RM dysfunction in CAP is associated with cytokine-mediated dysfunction. The degree of cytokine involvement in this process depends on the severity of endogenous intoxication and the volume of alveolar inflammation.

1. Chuchalin A.G., Sinopal’nikov A.I., Kozlov R.S. et al. [Russian Respiratory Society Interregional association on clinical microbiology and antimicrobial chemotherapy Clinical guidelines on diagnosis, treatment and prevention of severe community acquired pneumonia in adults]. Pul’monologiya. 2014; (4): 13–48. DOI: 10.18093/0869-0189-2014-0-4-13-48 (in Russian).

2. Avdeev S.N. [Assessment of respiratory muscle strength in clinical practice]. Atmosfera. Pul’monologiya i allergologiya. 2008; (4): 12–17. Available at: https://cyberleninka.ru/article/n/otsenka-sily-dyhatelnyhmyshts-v-klinicheskoy-praktike/viewer (in Russian).

3. Gel’tser B.I., Kurpatov I.G., Dei A.A., Kozhanov A.G. [Respiratory muscles dysfunction and respiratory diseases]. Terapevticheskiy arkhiv. 2019; 91 (3): 93–100 DOI: 10.26442/00403660.2019.03.000108 (in Russian).

4. Gel’tser B.I., Kotel’nikov V.N., Shakhgel’dyan K.I., Kurpatov I.G. [The results of modeling the proper values of the strength of the respiratory muscles based on the method of artificial neural]. Rossiyskiy fiziologicheskiy zhurnal im. I.M.Sechenova. 2018; 104 (9): 1065–1074. DOI: 10.7868/S0869813918090058 (in Russian).

5. Borodin E.A.,Egorshina E.V.,Samsonov V.P. [Biochemistry of endotoxemia. Pathogenic mechanisms and the estimation of the degree of severity at the inflammatory lung diseases]. Blagoveshchensk: AGMA; 2003 (in Russian).

6. Plekhova N.G., Kodrashova N.M., Geltser B.I., Kotelnikov V.N. [Cellular and molecular factors of innate defense and its role in the pathogenesis of pneumonia]. Immunologiya. 2017; 38 (2): 124–129. Available at: https://cyberleninka.ru/article/n/kletochno-molekulyarnye-faktory-vrozhdennoy-zaschity-i-ih-rol-v-patogeneze-pnevmonii/viewer (in Russian).

7. Aleksandrova N.P. [Cytokines and resistive respiration]. Fiziologiya cheloveka. 2012; 38 (2): 119–129. Available at: http://naukarus.com/tsitokiny-i-rezistivnoe-dyhanie (in Russian).

8. Kapilevich L.V., Kabachkova A.V., Zakharova A.N. et al. [Secretory function of skeletal muscles: producing mechanisms and myokines physiological effects]. Uspekhi fiziologicheskikh nauk. 2016; 47 (2): 7–26 (in Russian).

9. Gel’tser B.I., Dei A.A., Titorenco I.N., Kotel’nikov V.N. [Assessment of the strength of the respiratory muscles in community-acquired pneumonia]. Voenno-meditsinskiy zhurnal. 2018; 339 (11): 27–33 (in Russian).

10. Smirnova O.V., Kostyunina D.S., Ivanova A.D. [Myostatin: Twenty years later]. Fiziologiya cheloveka. 2018; 44 (1): 99–114. DOI: 10.7868/S0131164618010125 (in Russian).

11. Kalinina E.P., Gel’tser B.I., Kurpatov I.G. et al. [Evaluation of cytokine-mediated mechanisms involved in development of respiratory muscle dysfunction in the patients with chronic obstructive pulmonary disease]. Meditsinskaya immunologiya. 2019; 21 (3): 487–494. DOI: 10.15789/1563-0625-2019-3-487-494 (in Russian).

12. Kotelnikov V.N., Karpenko A.A., Kim A.P., Gel’tser B.I. [Ultrastructural AFM markers of endogenous intoxication in community-acquired pneumonia]. Sovremennye tekhnologii v meditsine. 2017; 9 (2): 53–60. DOI: 10.17691/stm2017.9.2.06 (in Russian).

13. Ust’yantseva I.M., Petukhova O.V., Skopintsev M.A. [Blood cytokines of patients with community-acquired pneumonia, taking into account the severity of the condition]. Immunopatologiya, allergologiya, infektologiya. 2005; (4): 66–70 (in Russian).

14. Sabitova O.N., Sovalkin V.I. [Gene polymorphism and production of basic immunoregulatory cytokines in community-acquired pneumonia]. Omskiy nauchnyy vestnik. 2009; (1): 42–45. Available at: https://cyberleninka.ru/article/n/polimorfizm-genov-i-produktsiya-osnovnyh-immunoregulyatornyh-tsitokinov-pri-vnebolnichnoy-pnevmonii/viewer (in Russian).

15. Abbas A.K., Trotta E., Simeonov D.R. et al. Revisiting IL-2: Biology and therapeutic prospects. Sci. Immunol. 2018; 3 (25): eaat1482. DOI: 10.1126/sciimmunol.aat1482.

16. Pedersen B.K., Febbraio M.A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 2012; 8 (8): 457–465. DOI: 10.1038/nrendo.2012.49.

17. Nitahara-Kasahara Y., Takeda S., Okada T. Inflammatory predisposition predicts disease phenotypes in muscular dystrophy. Inflamm. Regen. 2016; 36: 14. DOI: 10.1186/s41232-016-0019-0.

18. McKay S., Sharma H.S. Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle. Respir. Res. 2002; 3 (1): 11. DOI: 10.1186/rr160.

19. McRae N., Forgan L., McNeill B. et al. Glucocorticoids improve myogenic differentiation in vitro by suppressing the synthesis of versican, a transitional matrix protein overexpressed in dystrophic skeletal muscles. Int. J. Mol. Sci. 2017; 18 (12): 2629. DOI: 10.3390/ijms18122629.